XML 61 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
TriVascular Merger (Pro-Forma Information) (Details) - TriVascular Technologies, Inc. - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2016
Business Acquisition [Line Items]      
Combined net loss from continuing operations   $ 50,974 $ 96,011
Combined net loss from continuing operations   $ (62,507) $ (110,730)
Pro forma basic net loss per share (in dollars per share)   $ (0.76) $ (1.35)
Pro forma diluted net loss per share (in dollars per share) $ (0.76)